JP2004531697A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004531697A5 JP2004531697A5 JP2002558684A JP2002558684A JP2004531697A5 JP 2004531697 A5 JP2004531697 A5 JP 2004531697A5 JP 2002558684 A JP2002558684 A JP 2002558684A JP 2002558684 A JP2002558684 A JP 2002558684A JP 2004531697 A5 JP2004531697 A5 JP 2004531697A5
- Authority
- JP
- Japan
- Prior art keywords
- nogo
- bace
- polypeptide
- modulator
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000010410 Nogo Proteins Human genes 0.000 claims 16
- 108010077641 Nogo Proteins Proteins 0.000 claims 16
- 238000000034 method Methods 0.000 claims 15
- 102100021257 Beta-secretase 1 Human genes 0.000 claims 13
- 101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 claims 13
- 229920001184 polypeptide Polymers 0.000 claims 13
- 102000004196 processed proteins & peptides Human genes 0.000 claims 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims 13
- 230000000694 effects Effects 0.000 claims 11
- 239000012634 fragment Substances 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 4
- 108091005804 Peptidases Proteins 0.000 claims 3
- 239000004365 Protease Substances 0.000 claims 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 238000012544 monitoring process Methods 0.000 claims 3
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 claims 1
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 claims 1
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 claims 1
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 claims 1
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 claims 1
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0101313.5A GB0101313D0 (en) | 2001-01-18 | 2001-01-18 | Assay |
| PCT/GB2002/000214 WO2002058323A2 (en) | 2001-01-18 | 2002-01-18 | Method for identifying modulators of bace |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004531697A JP2004531697A (ja) | 2004-10-14 |
| JP2004531697A5 true JP2004531697A5 (https=) | 2005-12-22 |
Family
ID=9907053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002558684A Pending JP2004531697A (ja) | 2001-01-18 | 2002-01-18 | アッセイ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040146953A1 (https=) |
| EP (1) | EP1352084A2 (https=) |
| JP (1) | JP2004531697A (https=) |
| AU (1) | AU2002225169A1 (https=) |
| GB (1) | GB0101313D0 (https=) |
| WO (1) | WO2002058323A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0101312D0 (en) | 2001-01-18 | 2001-02-28 | Glaxo Group Ltd | Assay |
| US20060287501A1 (en) * | 2002-10-31 | 2006-12-21 | Pieris Proteolab Ag | Soluble truncated polypeptides of the nogo-a protein |
| JP2005145837A (ja) * | 2003-11-12 | 2005-06-09 | Institute Of Physical & Chemical Research | アルツハイマー病の診断方法 |
| CA2549956C (en) * | 2003-12-22 | 2016-04-12 | Glaxo Group Limited | Immunoglobulins |
| ES2400287T3 (es) * | 2005-03-14 | 2013-04-08 | High Point Pharmaceuticals, Llc | Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ304224B6 (cs) * | 1998-11-06 | 2014-01-15 | Schwab | Monoklonální protilátka |
| US7087399B1 (en) * | 1999-05-13 | 2006-08-08 | Scios, Inc. | β-secretase and modulation of β-secretase activity |
| IL150566A0 (en) * | 2000-01-12 | 2003-02-12 | Univ Yale | Nucleic acids and polypeptides and nogo-receptor proteins |
-
2001
- 2001-01-18 GB GBGB0101313.5A patent/GB0101313D0/en not_active Ceased
-
2002
- 2002-01-18 EP EP02715521A patent/EP1352084A2/en not_active Withdrawn
- 2002-01-18 JP JP2002558684A patent/JP2004531697A/ja active Pending
- 2002-01-18 AU AU2002225169A patent/AU2002225169A1/en not_active Abandoned
- 2002-01-18 US US10/466,391 patent/US20040146953A1/en not_active Abandoned
- 2002-01-18 WO PCT/GB2002/000214 patent/WO2002058323A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ramos-Cejudo et al. | Traumatic brain injury and Alzheimer's disease: the cerebrovascular link | |
| Chodavarapu et al. | Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion | |
| MX2019005415A (es) | Anticuerpos de il-6 y uso de los mismos. | |
| WO2006036744A3 (en) | Methods for a global assay of coagulation and fibrinolysis | |
| WO2006081521A3 (en) | Methods for diagnosis and intervention of hepatic disorders | |
| FR2870349A1 (fr) | Methode pour diagnostiquer la presence et/ou la severite d'une pathologie hepatique chez un sujet et/ou pour suivre l'efficacite d'un traitement d'une telle pathologie | |
| WO2008137838A3 (en) | Interferon alpha-induced pharmacodynamic markers | |
| ATE488765T1 (de) | Verfahren zum frühen nachweis einer nierenkrankheit und -verletzung | |
| Szabo et al. | Matrix metalloproteinases and the immune response | |
| DE60230320D1 (de) | Diagnose von einer klinischen infektion einer wunde | |
| Zhang et al. | Sink hypothesis and therapeutic strategies for attenuating Aβ levels | |
| JP2004531697A5 (https=) | ||
| WO2007038115A3 (en) | Ppar-gamma agonists for improvement of cognitive function in apoe4 negative patients | |
| ATE451477T1 (de) | Diagnose und überwachung von hepatozellulärem karzinom | |
| JP2014529606A5 (https=) | ||
| WO2002010357A3 (en) | Gsk3 polypeptides | |
| Kiser et al. | Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin‐induced thrombocytopenia | |
| DE602005023009D1 (de) | Verfahren in echtzeit zur erkennung von akuten entzündungszuständen | |
| JP2004520041A5 (https=) | ||
| RU2005109094A (ru) | Способ диагностики перинатальных гипоксических поражений головного мозга у доношенных новорожденных | |
| Ibrahim et al. | Depression among Egyptian End Stage Renal Disease Patients Under Maintenance Hemodialysis. | |
| DE60223729D1 (de) | Verbindungen zur diagnose und überwachung von erkrankungen in zusammenhang mit der bildung von amyloidfibrillen | |
| Chan et al. | Pragmatic comparison of β2-agonist side effects within the Worldwide Atosiban versus Beta Agonists study | |
| WO2002075317A3 (en) | Screening for drugs against disorders associated with schizophrenia | |
| WO2006116688A3 (en) | Mif agonists and antagonists and therapeutic uses thereof |